Daniel specialises in advising and representing national and international clients in the life sciences sector. His focus is, among others, on all areas of pharmaceutical law, medical device law, pharmaceutical-advertising law, unfair competition law, and trademark law.

 

For more than 10 years, he has been coordinating and supervising disputes concerning competition law and trademark law for his clients and has, besides his specific focus on litigation, also longstanding experience in advising clients on regulatory and compliance matters, particularly, in the aforementioned areas of law. In context with managing litigation and advising his clients, Daniel is characterised by a strong client focus and his ability to find appropriate and efficient solutions to legal problems.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

AI software ChatGPT – actually a medical device?

27 mars 2023
Briefing

par Dr. Daniel Tietjen et Ennio Schwind, LL.M. Eur.

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

CJEU referral on violations of data protection law on the basis of competition law and on the interpretation of the concept of health data

24 mars 2023
Briefing

par Dr. Daniel Tietjen et Dr. David Klein, LL.M. (Univ. of Washington), CIPP/E

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Higher Regional Court of Hamm on the advertising ban in Sec. 12 HWG in the context of the COVID 19 pandemic

22 mars 2023
Briefing

par Dr. Daniel Tietjen et Katharina Hölle

Cliquer ici pour en savoir plus
Brevets et innovation

OLG Celle on the obligations of distributors under Art. 14 MDR when distributing non-compliant medical devices in the context of unfair competition law

22 mars 2023
Briefing

par Dr. Daniel Tietjen et Sherin Sayed

Cliquer ici pour en savoir plus

Autres avocats qui pourraient vous intéresser